A study published on World Prematurity Day in the American Journal of Obstetrics and Gynecology provides additional support for treatment with vaginal progesterone to reduce the risk of preterm birth in cases of a short cervix.
It has been further emphasized that vaginal progesterone also reduces the risk of neonatal complications and infant death when the mom-to-be has a short cervix. A shortened cervix is the most powerful predictor of preterm birth.
This is welcome news when considering that the rate of preterm birth in the United States continued to increase in 2016 after a period of decline.
The research was undertaken by the Wayne State University School of Medicine and the Detriot Medical Center.
Read more about this study in this ScienceDaily article: